SLV News 20.25 07/01/2014 05:26:13 Silver Trust Ishares (SLV

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Silver Trust Ishares (SLV) 20.25 $SLV

Do Geopolitics Still Have a Firm Hold on Commodities, Oil, Gold?
at The Street - Fri Jun 27, 12:33PM CDT
Middle Eastern tensions might seem bullish for oil. But there are other factors to consider for commodities investors.

'Fast Money' Recap: Can GM Shares Drive Through $38?
at The Street - Thu Jun 26, 4:00AM CDT
The trading panel discussed whether General Motors and Google are worth buying.

Look for Shares of iShares Silver Trust to Potentially Pullback after Yesterday's 4.57% Rise
Comtex SmarTrend(R) - Thu Jun 19, 3:43PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $19.36 to a high of $20.10. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $19.07 on volume of 24.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Reasons to Buy Silver Wheaton Corp Over Silver ETFs
Lior Cohen, The Motley Fool - Motley Fool - Wed Jun 18, 2:56PM CDT
In the past couple of weeks, the silver market has slowly recovered, raising investor interest in silver-related assets such as the  iShares Silver Trust .  Silver Wheaton , however, may offer several advantages over a direct investment in a silver...

Iraq’s ISIS Crisis: What Investors Need to Know
Leo Sun, The Motley Fool - Motley Fool - Wed Jun 18, 12:20PM CDT
ISIS, or The Islamic State in Iraq and the Levant, also known as ISIL, a militant group once deemed too violent and radical by al-Qaeda, is currently sweeping across both Iraq and Syria in an aggressive push to unify both nations into a single state....

How the Silver Market Gets Hurt by the World Cup
at The Street - Mon Jun 16, 10:30AM CDT
UBS explains why the silver market will see even slower trading during the next month compared against prior summers.

SmarTrend Watching for Potential Pullback in Shares of iShares Silver Trust After 1.63% Gain
Comtex SmarTrend(R) - Thu Jun 12, 4:31PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.52 to a high of $18.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $18.50 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Silver Trust Set to Possibly Pullback After Yesterday's Rally of 1.63%
Comtex SmarTrend(R) - Thu Jun 12, 4:31PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.52 to a high of $18.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $18.50 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Reasons Why Gold Continues to Flatline
James Catlin, The Motley Fool - Motley Fool - Wed Jun 11, 8:56AM CDT
If you're puzzled why large injections into the money supply have failed to send gold prices higher, you're not alone. The answer is not so simple, since many factors can have an impact on the price of gold. For now we will forget about politics and...

Non-Farm Payroll Data Just May Boost the Gold, Silver Market
at The Street - Thu Jun 05, 9:49AM CDT
Tomorrow the non-farm payroll report will be released; how the report will impact the gold market?

Precious Metals: A Golden Fall
at The Street - Mon Jun 02, 10:35AM CDT
Good new and bad news this week. Gold is in serious trouble -- but that means prices are low.

iShares Silver Trust Falls 1.61% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue May 27, 5:43PM CDT
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $18.29 to a high of $18.42. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $18.52 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Precious Metals: Tight Action Leads to Big Moves
at The Street - Mon May 26, 2:20PM CDT
Precious metals remain trapped within a tightening range for gold and silver, but there was an attempt to break gold.

Why Leveraged ETFs Can Be Dangerous Long-Term Investments
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 23, 1:10PM CDT
Exchange-traded funds are a great way to invest, but not all ETFs are the same. Leveraged ETFs can involve substantial risks, and you have to understand how your ETF works in order to assess and manage those risks. In this installment of our...

Tuesday, May 20: Today in Gold and Silver
at The Street - Tue May 20, 4:25AM CDT
Gold and silver stocks close marginally higher. No changes in either GLD or SLV. A tiny sales report from the U.S. Mint. Not much in/out movement in gold on Friday, but decent in/out movement in silver at the Comex-approved depositories.

Gold: Building a Base or Just Chopping Like Crazy?
at The Street - Mon May 19, 12:10PM CDT
It's another choppy week with no real direction. Textbook breakouts are failing, and it's very hard to catch a winner in the precious metals market.

Saturday, May 17: Today in Gold and Silver
at The Street - Sat May 17, 7:11AM CDT
Gold stocks down again, but silver equities rally! A tiny withdrawal from GLD---and no changes in SLV. No sales report from the U.S. Mint once again. No in/out movement in gold at the Comex-approved depositories on Thursday---and decent movement in...

Friday, May 16: Today in Gold and Silver
at The Street - Fri May 16, 4:26AM CDT
Gold and silver stocks give back all their Wednesday gains, plus more. A surprise deposit in GLD, but no change in SLV. No sales report from the U.S. Mint. No in/out movement in gold once again at the Comex-approved depositories on Wednesday, but a...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading